← All stocks

TREACE MEDICAL CONCEPTS, INC.

TMCI Net buying

CIK 0001630627 #3615 in the set updated 17 Sep 2026

Bought (12 mo)

$1.35M

out of their own pocket, the only kind of buying there is

Sold (12 mo)

$0.00

$0.00 on a plan · $0.00 straight out of an exercise

Sold at will

$0.00

0 of 0 sales

Net

+$1.35M

+$1.35M against sales at will

By person

13 insiders · 14 transactions

42.5×

John T. Treace holds 42.5 times base salary in stock. $32.13M of shares against $755.35K in salary for 2025.

Salary from the company's own proxy. The shares are what John T. Treace last reported holding, valued at $4.34, the price Common Stock was last bought or sold at on the open market here, on 24 Aug 2026.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Treace John T.

Chief Executive Officer

$1.35M (12)

—

+$1.35M

7,404,383

11.39%

$32.13M

+14.0%

MOTT RICHARD W

Director

—

1,096,861

1.69%

$4.76M

+2.2%

Hair Mark

Chief Financial Officer

—

914,900

1.41%

$3.97M

+149.3%

Elder Scot Michael

Chief Legl & Comp Off, CorpSec

—

778,683

1.20%

$3.38M

+227.3%

Scanlan Sean F.

Chief Innovation Officer

—

679,863

1.05%

$2.95M

+237.9%

Guglielmino Gaetano

Chief Commercial Officer

—

490,901

0.7548%

$2.13M

—

Berutti Aaron

SVP, Sales

—

205,092

0.3154%

$889.94K

+44.1%

BAKEWELL JOHN K

Director

—

204,056

0.3138%

$885.44K

+35.9%

Jain Deepti

Director

—

100,243

0.1541%

$434.97K

+116.4%

Kiernan Jane E

Director

—

93,949

0.1445%

$407.66K

+134.7%

Hanna Betsy

Director

—

75,243

0.1157%

$326.49K

+252.8%

Berry Lance A

Director

—

74,593

0.1147%

$323.67K

+260.8%

HAMILTON LAWRENCE W

Director

—

74,056

0.1139%

$321.34K

+267.7%

Individual transactions

Insider

Date

Role

Action

Price

Amount

Scanlan Sean F.

10 Feb 2026

Chief Innovation Officer

Exercised, kept

16,875

$1.05

$17.72K

Scanlan Sean F.

21 Jan 2026

Chief Innovation Officer

Exercised, kept

53,500

$0.72

$38.52K

Show all 14 transactions →

What was left out

Form 4 filings counted 33

Amendments (4/A) skipped 1

Filings about a different issuer 0

Unreadable filings 0

Joint filings 0

Sales on a Rule 10b5-1 plan 0

Sales straight out of an exercise 0

Sales at will 0

Transactions with no price 0

Shares from compensation/vesting 1,847,879

History held since 26 Apr 2021